Pharmaceutical Technology

SEPTEMBER 20, 2022

Clinical packaging and labelling follow stringently controlled procedures and high-standard quality control measures to assure the safety and functionality of investigational medicinal products, during their storage, distribution, and use. Finding the best clinical trial packaging services providers.

Packaging 100

Packaging Packaging Marketing Clinical Trials 100

The Pharma Data

SEPTEMBER 24, 2020

Some supplements billed as ‘smart drugs’ may contain unapproved drugs in potentially dangerous combinations and doses, according to a new study. The team looked through the National Institute of Health’s Dietary Supplement Label Database and the Natural Medicines Database for products containing unapproved drugs. Conor Kavanagh.

Containment 52

Containment Drugs Production Engineer 52

Roots Analysis

AUGUST 16, 2023

mRNA has completely revolutionized the field of medicine and significantly influenced the study and treatment of human diseases. In the foreseen future, as more of such RNA-based leads mature and move into the clinic and / or get commercialised, we anticipate the mRNA synthesis and manufacturing services market to witness healthy growth.

Contract Manufacturing 52

Contract Manufacturing Manufacturing Marketing RNA 52

Drug Discovery World

FEBRUARY 12, 2024

Why has there been so little progress in medicine? When pharmacologist, Dr Bob Coleman, began his career with the pharmaceutical giant, Glaxo, his arrival coincided with the discovery of some well-known drugs such as the bronchodilator salbutamol (marketed as Ventolin) and beclomethasone (Becotide). Why has it been so unproductive?

Medicine 59

Medicine Genome Genomics Drugs 59

Pharmaceutical Technology

MARCH 31, 2023

The European Medicines Agency (EMA) has recommended HIPRA’s Covid-19 vaccine , Bimervax, as a Covid-19 booster. Available to people ages 16 years and above who have been vaccinated with a Covid-19 mRNA vaccine, EMA’s Human Medicines Committee concluded the vaccine is ready for marketing authorization in the EU, on 30 March.

Vaccination 277

Vaccination Vaccine Immune Response Antibody 277

Drug Discovery World

AUGUST 3, 2023

In the first part of this series of articles focused on plant-based medicines, DDW’s Megan Thomas evaluates the use of medical cannabis in drug discovery. Medical cannabis is often a first-thought when regarding plant-based medicines, but there remains public scepticism, arguably due to the regulations relating to the substance.

Medicine 52

Medicine Scientist Production Regulation 52

Drug Discovery World

FEBRUARY 1, 2023

Michael Sassano , CEO at SOMAÍ Pharmaceuticals looks at what’s needed throughout Europe to help increase access to medicinal cannabis and the current state of pharmaceutical research in this area. The use of medicinal cannabis across much of the world is still in its infancy. The GW Pharmaceuticals purchase by Jazz for $6.7

Clinical Trials 52

Clinical Trials Clinical Trials Medicine Trials 52

Pharmaceutical Technology

SEPTEMBER 5, 2022

Pharmaceutical wholesalers act as intermediaries between pharmaceutical manufacturers and retailers and facilitate the delivery of the right medicines in a timely, efficient, and secure manner. Worldwide sourcing and drop-ship of orphan medicines, and. Discover the top pharmaceutical wholesalers. GDP and GMP advisory.

Packaging 130

Packaging Packaging Compliance Manufacturing 130

Pharma in Brief

DECEMBER 3, 2023

This year marks the 30-year anniversary of the Patented Medicines (Notice of Compliance) Regulations ( Regulations ), introduced in 1993 to prevent patent infringement by linking the regulatory approval of generic or biosimilar drugs with the patent rights of innovators. Evolution of the Regulations Coming into force (1993–1997).

Regulation 52

Regulation Compliance Medicine Manufacturing 52

Pharma in Brief

AUGUST 5, 2020

DESCOVY contains a combination of tenofovir alafenamide ( TAF ) hemifumarate and emtricitabine. Because DESCOVY contains TAF, it benefits from the same data protection term granted to GENVOYA. GENVOYA and DESCOVY are both fixed-dose combination drugs marketed by Gilead for the treatment of HIV. Background.

Containment 52

Containment Drugs Regulation Medicine 52

Pharmaceutical Technology

MARCH 10, 2023

Lebanon’s ongoing economic crisis and changes in pricing strategies have caused monumental price hikes that impact market access. In Lebanon, the battle for access to medicines rages on and is further heightened by dramatic decreases to the healthcare budget last year.

Marketing 130

Marketing Branding Manufacturing Medicine 130

Roots Analysis

MARCH 8, 2023

It is worth noting that smart labels contain a transponder code which can be read by sophisticated devices, including radio frequency identification device (RFID) tags and near-field communication (NFC) chips. These smart labels thus assist in preventing counterfeit pharmaceutical / medical products coming into the market.

Medicine 52

Medicine Production Manufacturing Containment 52

Pharmaceutical Technology

MAY 25, 2023

The results from a trial, published in The New England Journal of Medicine , found the vaccine was associated with a strong immune response and good safety profile. The response was more powerful than that generated by MenACWY-D – a licensed quadrivalent meningococcal vaccine marketed by GSK. percentage points (96% CI, −0.3

Vaccination 195

Vaccination Vaccine Immune Response Bacteria 195

Scienmag

APRIL 19, 2021

News from the Journal of Marketing Newly published research contained in the Special Issue of the Journal of Marketing features fourteen global author teams focused on the topic of Better Marketing for a Better World.

Marketing 40

Marketing Containment Research Development 40

Drug Discovery World

AUGUST 14, 2023

Over the past few decades, the incredible progress in personalised medicine has led to the development of life-saving cell and gene therapies (CGT). Driven by the rapid pace of innovation, the market for CGTs is expected to grow from $4.4 And the robust CGT pipeline suggests there could be an influx of new approvals on the horizon.

Gene Therapy 52

Gene Therapy Marketing Gene DNA 52

Pfizer

JANUARY 27, 2023

One carton contains five blister packs of PAXLOVID, as co-packaged nirmatrelvir tablets with ritonavir tablets, providing all required doses for a full five-day treatment course. Disclosure Notice The information contained in this statement is as of January 27, 2023.

Marketing 75

Marketing Production Drugs Licensing 75

Delveinsight

JANUARY 22, 2021

The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market. At present, there stands no treatment option that can cure the disease.

Marketing 65

Marketing Drugs Antibody Compliance 65

The Pharma Data

MAY 8, 2021

The study aims to confirm that the proposed biosimilar has equivalent efficacy and comparable safety to the reference medicine* in patients with nAMD 1. Sandoz biosimilars help patients to access advanced biologic medicines more sustainably and affordably. Disclaimer.

Clinical Development 52

Clinical Development Medicine Development Containment 52

The Pharma Data

OCTOBER 29, 2020

Tokyo, Japan) today announced that the European Medicines Agency (EMA) has confirmed it has accepted for review, following a standard timetable, the Marketing Authorization Application (MAA) for aducanumab, an investigational treatment for Alzheimer’s disease. . CAMBRIDGE, Mass. and TOKYO, Oct. please visit [link].

Medicine 40

Medicine Marketing Clinical Trials Clinical Trials 40

Pharmaceutical Technology

MAY 25, 2023

With a network of more than 134 local pharmaceutical companies, Adalvo supplies more than 110 different medicines in over 100 countries across the world. Mellozzan contains the sleep hormone melatonin and is indicated for use in children with attention deficit hyperactivity disorder (ADHD) and sleep difficulties.

Hormones 130

Hormones Engineer Licensing Licensing 130

XTalks

FEBRUARY 15, 2024

As Good Measures and Instacart plan to expand the Good Food Prescription program, they lead the Food as Medicine movement. The team applauds this program’s efforts, comparing it to traditional prescriptions. Subscribe to the Xtalks Food Podcast to never miss a new episode.

Containment 111

Containment Marketing Medicine Production 111

FDA Law Blog

JANUARY 3, 2024

Palmer & Riëtte van Laack — Most of us love our furry friends, and with the boom in pet ownership during the pandemic, it is no surprise that the market for pet products has become enormous. Enter the FDA’s Center for Veterinary Medicine (“CVM”).

Drugs 59

Drugs Production Licensing Licensing 59

Pharma in Brief

JANUARY 15, 2024

The Federal Court ( FC ) has refused to overturn a decision of the Patented Medicine Prices Review Board ( PMPRB or Board ) that found that a patent can pertain to a medicine based on “clinical similarities” to the invention—even if the patent does not actually encompass the medicine. The patentee, Galderma Canada Inc.

Dermatology 52

Dermatology Medicine Containment Production 52

Pharma in Brief

SEPTEMBER 8, 2022

On August 17, 2022, the Federal Court dismissed applications for judicial review regarding the product-specificity requirements for addressing patents listed on the Patent Register under the Patented Medicines (Notice of Compliance) Regulations (the Regulations ). Background. The Minister’s decisions. Sections 4 and 5 work together.

Marketing 52

Marketing Drugs Regulation Compliance 52

Delveinsight

OCTOBER 1, 2021

There are several therapies in the market to address the Myasthenia Gravis burden, and many companies are still working on their drug candidates to cope with Myasthenia Gravis. The current Myasthenia Gravis therapeutics market has many FDA-approved drugs for the treatment of Myasthenia Gravis. Myasthenia Gravis Approved Therapies.

Marketing 85

Marketing Antibody Drugs Sales 85

The Pharma Data

AUGUST 31, 2020

Portfolio of 15 generic and over-the-counter (OTC) medicines from Sandoz division will be sold at zero- profit to governments through Africa Medical Supplies Platform (AMSP) to 55 African and 15 Caricom eligible countries . This is because they did not have access to essential medicines needed for treatment.

Medicine 52

Medicine Containment Production Development 52

Delveinsight

AUGUST 17, 2021

Food and Drug Administration gave a red flag to FibroGen’s anemia pill roxadustat, for the use in patients suffering from kidney diseases owing to safety concerns that arose after results, which in turn are concluded for the presentation of further clinical studies to assess safety for future medicinal use.

FDA Approval 98

FDA Approval Medicine Vaccination Vaccine 98

The Pharma Data

MAY 27, 2022

ViiV Healthcare has today announced that it is committing to license its patents relating to cabotegravir long-acting (LA) for HIV pre-exposure prophylaxis (PrEP) and is entering into negotiation on voluntary licensing terms with the UN-backed Medicines Patent Pool (MPP). ViiV Healthcare has submitted marketing applications in?

Medicine 52

Medicine Licensing Licensing Manufacturing 52

Pharma in Brief

JULY 7, 2020

The Patented Medicine Prices Review Board ( PMPRB or Board ) has found that a patent can pertain to a medicine based on clinical similarities to the invention—even if the patent does not actually encompass the medicine. Galderma ), markets two adapalene products in Canada: Differin ® , which contains 0.1%

Medicine 40

Medicine Dermatology Containment Production 40

Pfizer

SEPTEMBER 25, 2022

Medicines, Research. Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union. Pfizer and Sangamo Therapeutics Announce Phase 3 Trial of Investigational Gene Therapy for Hemophilia A Has Re-Opened Recruitment.

Gene Therapy 89

Gene Therapy Containment Medicine Gene 89

The Pharma Data

MAY 5, 2021

Sanofi Forward-Looking Statements This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe. . . Sanofi, Empowering Life. .

Medicine 52

Medicine Research Containment Production 52

The Pharma Data

OCTOBER 15, 2020

15, 2020 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. The shares are expected to begin trading on the Nasdaq Global Select Market on October 16, 2020 under the ticker symbol “PRAX.” CAMBRIDGE, Mass., The offering is expected to close on October 20, 2020, subject to the satisfaction of customary closing conditions.

Medicine 40

Medicine Containment Genetics Sales 40

The Pharma Data

MAY 2, 2021

With eight marketed biosimilar medicines globally and 15+ molecules in pipeline, Sandoz is investing in future of biosimilars for patients and healthcare systems. The study aims to confirm that the proposed biosimilar has equivalent efficacy and comparable safety to the reference medicine* in patients with nAMD 1. Disclaimer.

Clinical Development 40

Clinical Development Medicine Development Production 40

The Pharma Data

JULY 15, 2021

The UK Competition and Markets Authority has cleared AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals, Inc. In addition, the new AstraZeneca American Depositary Shares (ADSs) will be admitted on the Nasdaq Stock Market. listed from the Nasdaq Stock Market. In addition, the Alexion shares will be de?listed

Marketing 52

Marketing Containment Regulation Medicine 52

Drug Discovery World

DECEMBER 6, 2023

The UK government has published new terms for the Statutory Scheme for branded medicines, which controls the prices of medicines paid by the NHS. This means that companies will pay a rebate on the sales of branded medicines to the NHS of 21.9% in 2024, 24% in 2025 and 26.8% While the published rates are down on the record 27.5%

Life Science 59

Life Science Branding Medicine Pharma Companies 59

pharmaphorum

JANUARY 20, 2022

According to the company, the defendants reportedly sold 85,247 bottles of medicine with counterfeit Gilead labelling to pharmacies over a two-year period, using falsified supply chain documentation to conceal their origin. This works to ensure the safety and efficacy of the drugs received by patients.

Drugs 110

Drugs Medicine Containment Branding 110

Pharmaceutical Technology

JULY 29, 2022

Once new vaccines for the Omicron variant are approved, they will partly make up for the waning interest in older Covid boosters in developed markets. Pfizer completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted bivalent Covid-19 vaccine candidate, based on the BA.1 1 sub-lineage on 19 July.

Manufacturing 130

Manufacturing Vaccination Vaccine Packaging 130